A nonionic polyoxyethylene-polyoxypropylene block co-polymer with the general formula HO(C2H4O)a(-C3H6O)b(C2H4O)aH. It is available in different grades which vary from liquids to solids. It is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater. (Martindale The Extra Pharmacopoeia, 31st ed)
A copolymer of polyethylene and polypropylene ether glycol. It is a non-ionic polyol surface-active agent used medically as a fecal softener and in cattle for prevention of bloat.
Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.
Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect.
Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc.
Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.
A plant genus of the family FABACEAE.
The preparation, mixing, and assembling of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814)
Nanometer-sized, hollow, spherically-shaped objects that can be utilized to encapsulate small amounts of pharmaceuticals, enzymes, or other catalysts (Glossary of Biotechnology and Nanobiotechnology, 4th ed).
Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
An excessive amount of fluid in the cornea due to damage of the epithelium or endothelium causing decreased visual acuity.
The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients.
Relating to the size of solids.
Sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals.
A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.
The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed)
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS.
The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms.
Salts that melt below 100 C. Their low VOLATILIZATION can be an advantage over volatile organic solvents.

Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers. (1/274)

Ethylene oxide and propylene oxide block copolymers (pluronics) are widely known as agents that promote drug penetration across biological barriers. We have studied the interaction of normal and malignant blood cells with pluronics L61 and P85 that have different hydrophobicity. SP2/0 myeloma cells accumulated pluronics while normal cells adsorb most of the polymer on the surface. Interaction of pluronics with cells resulted in drastic changes of membrane microviscosity. Tumor cell membrane microviscosity decreased after pluronics adsorption, in contrast to normal cells, whose membrane microviscosity was enhanced. We suppose that sensitivity of tumor cell membrane microviscosity to the pluronics action correlates with its permeability for molecular substances.  (+info)

Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. (2/274)

To develop a cell culture model for chyclomicron (CM) assembly, the apical media of differentiated Caco-2 cells were supplemented with oleic acid (OA) together with either albumin or taurocholate (TC). The basolateral media were subjected to sequential density gradient ultracentrifugations to obtain large CM, small CM, and very low density lipoproteins (VLDL), and the distribution of apoB in these fractions was quantified. In the absence of OA, apoB was secreted as VLDL/LDL size particles. Addition of OA (>/=0.8 mM) with TC, but not with albumin, resulted in the secretion of one-third of apoB as CM. Lipid analysis revealed that half of the secreted phospholipids (PL) and triglycerides (TG) were associated with CM. In CM, TG were 7-11-fold higher than PL indicating that CM were TG-rich particles. Secreted CM contained apoB100, apoB48, and other apolipoproteins. Secretion of large CM was specifically inhibited by Pluronic L81, a detergent known to inhibit CM secretion in animals. These studies demonstrate that differentiated Caco-2 cells assemble and secrete CM in a manner similar to enterocytes in vivo. Next, experiments were performed to identify the sources of lipids used for lipoprotein assembly. Cells were labeled with [3H]glycerol for 12 h, washed, and supplemented with OA, TC, and [14C] glycerol for various times to induce CM assembly and to radiolabel nascent lipids. TG and PL were extracted from cells and media and the association of preformed and nascent lipids with lipoproteins was determined. All the lipoproteins contained higher amounts of preformed PL compared with nascent PL. VLDL contained equal amounts of nascent and preformed TG, whereas CM contained higher amounts of nascent TG even when nascent TG constituted a small fraction of the total cellular pool. These studies indicate that nascent TG and preformed PL are preferentially used for CM assembly and provide a molecular explanation for the in vivo observations that the fatty acid composition of TG, but not PL, of secreted CM reflects the composition of dietary fat. It is proposed that in the intestinal cells the preformed PL from the endoplasmic reticulum bud off with apoB as primordial particles and the assembly of larger lipoproteins is dependent on the synthesis and delivery of nascent TG to these particles.  (+info)

Activities of poloxamer CRL-1072 against Mycobacterium avium in macrophage culture and in mice. (3/274)

Earlier studies reported that certain large hydrophobic poloxamer surfactants were able to inhibit the growth of Mycobacterium avium-M. intracellulare complex (MAI) in broth and to produce synergistic enhancement of the activity of rifampin. CRL-1072 was synthesized to have an optimal structure for antimicrobic effects and greater purity. Its MIC for MAI in broth was greater than 100 microg/ml. Surprisingly, its MIC for MAI growing in human U937 monocytoid cells was much lower, 5 microg/ml. A still lower concentration, 0.1 microg/ml, produced synergistic enhancement of the activities of clarithromycin, rifampin, amikacin, streptomycin, and clindamycin, but not isoniazid, against MAI infecting monocytoid cells. Mice tolerated injection of doses of CRL-1072 as high as 125 mg/kg of body weight. Pharmacokinetic analysis revealed that the copolymer had an elimination half-life of 60 h and suggested dosing regimens that might produce therapeutic concentrations in tissue. In a mouse model of acute MAI infection, CRL-1072 significantly enhanced the bactericidal activities of clarithromycin and rifampin when it was administered at 1.0 mg/kg intravenously (i.v.) three times per week. CRL-1072 given i.v. or orally also enhanced the bactericidal activity of clindamycin against MAI.  (+info)

Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats. (4/274)

A substantial body of evidence indicates that aged-related changes in the fluidity and lipid composition of the plasma membrane contribute to cellular dysfunction in humans and other mammalian species. In the CNS, reductions in neuronal plasma membrane order (PMO) (i.e., increased plasma membrane fluidity) have been attributed to age as well as the presence of the beta-amyloid peptide-25-35, known to play an important role in the neuropathology of Alzheimer's disease (AD). These PMO increases may influence neurotransmitter synthesis, receptor binding, and second messenger systems as well as signal transduction pathways. The effects of neuronal PMO on learning and memory processes have not been adequately investigated, however. Based on the hypothesis that an increase in PMO may alter a number of aspects of synaptic transmission, we investigated several neurochemical and behavioral effects of the membrane ordering agent, PF-68. In cell culture, PF-68 (nmoles/mg SDS extractable protein) reduced [3H]norepinephrine (NE) uptake into differentiated PC-12 cells as well as reduced nicotine stimulated [3H]NE release. The compound (800-2400 microg/kg, i.p., resulting in nmoles/mg SDS extractable protein in the brain) decreased step-through latencies and increased the frequencies of crossing into the unsafe side of the chamber in inhibitory avoidance training. In the Morris water maze, PF-68 increased the latencies and swim distances required to locate a hidden platform and reduced the time spent and distance swam in the previous target quadrant during transfer (probe) trials. PF-68 did not impair performance of a well-learned working memory task, the rat delayed stimulus discrimination task (DSDT), however. Studies with 14C-labeled PF-68 indicated that significant (pmoles/mg wet tissue) levels of the compound entered the brain from peripheral (i.p.) injection. No PF-68 related changes were observed in swim speeds or in visual acuity tests in water maze experiments, rotorod performance, or in tests of general locomotor activity. Furthermore, latencies to select a lever in the DSDT were not affected. These results suggest that PF-68 induced deficits in learning and memory without confounding peripheral motor, sensory, or motivational effects at the tested doses. Furthermore, none of the doses induced a conditioned taste aversion to a novel 0.1% saccharin solution indicating a lack of nausea or gastrointestinal malaise induced by the compound. The data indicate that increases in neuronal plasma membrane order may have significant effects on neurotransmitter function as well as learning and memory processes. Furthermore, compounds such as PF-68 may also offer novel tools for studying the role of neuronal PMO in mnemonic processes and changes in PMO resulting from age-related disorders such as AD.  (+info)

Control of staphylococcal adhesion to polymethylmethacrylate and enhancement of susceptibility to antibiotics by poloxamer 407. (5/274)

We studied the antiadhesive effect of Poloxamer 407 (P407), together with modifications in the antimicrobial susceptibility of residual adherent staphylococci. Bacterial adherence was markedly inhibited (77% to more than 99.9%) whether polymethylmethacrylate was exposed to P407 before or during the adherence assay. Furthermore, residual adherent staphylococci appeared to be more susceptible to antibiotic activity, suggesting that combination of P407 with antibiotics could be a promising approach to the prevention of infection of foreign material.  (+info)

A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. (6/274)

Intramuscular administration of plasmid DNA is a promising strategy to express therapeutic genes, however, it is limited by a relatively low level of gene expression. We report here that a non-ionic carrier, SP1017, composed of two amphiphilic block copolymers, pluronics L61 and F127, also known as poloxamers, significantly increases intramuscular expression of plasmid DNA. Two reporter genes, luciferase and beta-galactosidase, and one therapeutic gene, erythropoietin, were injected intramuscularly with and without SP1017 into C57Bl/6 and Balb/C mice and Sprague-Dawley rats. SP1017 increased gene expression by about 10-fold and maintained higher gene expression compared with naked DNA. Comparison of SP1017 with polyvinyl pyrrolidone (PVP) showed that SP1017 exhibited a significantly higher efficacy and its optimal dose was 500-fold lower. Experiments with beta-galactosidase using X-gal staining suggested that SP1017 considerably increased plasmid DNA diffusion through the tissue. SP1017 also improved expression of the erythropoietin gene leading to an increase in its systemic level and hematocrits. Previous toxicity studies have suggested that SP1017 has over a 1000-fold safety margin. Poloxamers used in SP1017 are listed in the US Pharmacopeia as inactive excipients and are widely used in a variety of clinical applications. We believe that the described system constitutes a simple and efficient gene transfer method to achieve local or systemic production of therapeutic proteins.  (+info)

In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188. (7/274)

A micellar formulation of amphotericin B (AmB) solubilized with poloxamer 188 was evaluated against an AmB Leishmania donovani-resistant line. A concave isobologram showed a synergistic effect of this association against promastigotes. This result was confirmed with amastigotes since the 50% effective concentration of the new formulation was 100 times less than that of the control AmB formulation.  (+info)

The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation). (8/274)

OBJECTIVES: To examine the impact of time to thrombolytic treatment on multiple acute outcome variables in a single trial of thrombolysis in acute myocardial infarction. DESIGN AND PATIENTS: Mortality and reinfarction rate were measured in 2770 patients with acute myocardial infarction who received thrombolysis within 12 hours in CORE, an international, dose ranging trial of poloxamer 188. Tc-99m sestamibi infarct size and radionuclide angiographic ejection fraction substudies included 1099 and 1074 patients, respectively. RESULTS: Time to thrombolysis, subgrouped by intervals (< 2, 2-4, > or = 4-6, and > or = 6 hours), was significantly associated with infarct size (median 15.0%, 18.5%, 22.0%, 18.5% of left ventricle; p = 0.033), mean (SD) ejection fraction (51.5 (12.0)%, 48. 3 (13.9)%, 48.2 (13.3)%, 48.2 (15.0)%; p = 0.006), 35 day mortality (5.7%, 7.1%, 7.9%, 12.5%; p = 0.0004), six month mortality (7.3%, 8. 6%, 10.4%, 15.5%; p < 0.0001), and 35 day reinfarction rate (6.1%, 3. 2%, 4.0%, 0.9%; p = 0.0001). CONCLUSIONS: In this single large trial, the beneficial effect of time to thrombolysis on infarct size and ejection fraction was restricted to treatment given within two hours of symptom onset, while the effect on mortality was evident over all time intervals. Reinfarction rate was higher in patients treated with earlier thrombolysis.  (+info)

Poloxamers are a type of triblock copolymer made up of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). They are amphiphilic molecules, meaning they have both hydrophilic and hydrophobic parts.

Poloxamers are often used in the pharmaceutical industry as drug delivery agents, emulsifiers, solubilizers, and stabilizers. They can form micelles in aqueous solutions above their critical micelle concentration (CMC), with the hydrophobic chains oriented toward the interior of the micelle and the hydrophilic chains on the exterior, interacting with the water molecules. This unique property allows poloxamers to solubilize drugs that are otherwise poorly soluble in water, improving their bioavailability.

Poloxamers have been studied for various medical applications, including as drug carriers for chemotherapy, diagnostic agents, and mucoadhesive materials. Some specific poloxamer compounds have been approved by the FDA for use in pharmaceutical formulations, such as Poloxamer 188 and Poloxamer 407.

In a medical context, poloxamers are not typically used as standalone treatments but rather as components of drug delivery systems or formulations.

Poloxalene is not a medical term, but a chemical compound. It's an ether used as a non-ionic surfactant and emulsifying agent in the pharmaceutical industry. Poloxalene is also known for its ability to reduce the severity of bloat (gas distention) in animals, particularly in ruminants like cows, when included in their feed. However, it's not typically used as a human medication.

Surfactants, also known as surface-active agents, are amphiphilic compounds that reduce the surface tension between two liquids or between a liquid and a solid. They contain both hydrophilic (water-soluble) and hydrophobic (water-insoluble) components in their molecular structure. This unique property allows them to interact with and stabilize interfaces, making them useful in various medical and healthcare applications.

In the medical field, surfactants are commonly used in pulmonary medicine, particularly for treating respiratory distress syndrome (RDS) in premature infants. The lungs of premature infants often lack sufficient amounts of natural lung surfactant, which can lead to RDS and other complications. Exogenous surfactants, derived from animal sources or synthetically produced, are administered to replace the missing or dysfunctional lung surfactant, improving lung compliance and gas exchange.

Surfactants also have applications in topical formulations for dermatology, as they can enhance drug penetration into the skin, reduce irritation, and improve the spreadability of creams and ointments. Additionally, they are used in diagnostic imaging to enhance contrast between tissues and improve visualization during procedures such as ultrasound and X-ray examinations.

A dosage form refers to the physical or pharmaceutical preparation of a drug that determines how it is administered and taken by the patient. The dosage form influences the rate and extent of drug absorption, distribution, metabolism, and excretion in the body, which ultimately affects the drug's therapeutic effectiveness and safety profile.

There are various types of dosage forms available, including:

1. Solid dosage forms: These include tablets, capsules, caplets, and powders that are intended to be swallowed or chewed. They may contain a single active ingredient or multiple ingredients in a fixed-dose combination.
2. Liquid dosage forms: These include solutions, suspensions, emulsions, and syrups that are intended to be taken orally or administered parenterally (e.g., intravenously, intramuscularly, subcutaneously).
3. Semi-solid dosage forms: These include creams, ointments, gels, pastes, and suppositories that are intended to be applied topically or administered rectally.
4. Inhalation dosage forms: These include metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers that are used to deliver drugs directly to the lungs.
5. Transdermal dosage forms: These include patches, films, and sprays that are applied to the skin to deliver drugs through the skin into the systemic circulation.
6. Implantable dosage forms: These include surgically implanted devices or pellets that release drugs slowly over an extended period.

The choice of dosage form depends on various factors, such as the drug's physicochemical properties, pharmacokinetics, therapeutic indication, patient population, and route of administration. The goal is to optimize the drug's efficacy and safety while ensuring patient compliance and convenience.

Excipients are inactive substances that serve as vehicles or mediums for the active ingredients in medications. They make up the bulk of a pharmaceutical formulation and help to stabilize, preserve, and enhance the delivery of the active drug compound. Common examples of excipients include binders, fillers, coatings, disintegrants, flavors, sweeteners, and colors. While excipients are generally considered safe and inert, they can sometimes cause allergic reactions or other adverse effects in certain individuals.

Pharmaceutical chemistry is a branch of chemistry that deals with the design, synthesis, and development of chemical entities used as medications. It involves the study of drugs' physical, chemical, and biological properties, as well as their interactions with living organisms. This field also encompasses understanding the absorption, distribution, metabolism, and excretion (ADME) of drugs in the body, which are critical factors in drug design and development. Pharmaceutical chemists often work closely with biologists, medical professionals, and engineers to develop new medications and improve existing ones.

"Sophora" does not have a specific medical definition, but it is a term that refers to various species of the Sophora plant genus, which belongs to the Fabaceae (legume) family. Some of these plants have been used in traditional medicine in different cultures.

For instance, Sophora flavescens (Ku Shen) has been used in Traditional Chinese Medicine for its anti-inflammatory, antiviral, and antipyretic properties. It contains several alkaloids, such as matrine and oxymatrine, which have demonstrated pharmacological activities.

Another example is Sophora japonica (Japanese pagoda tree), whose seeds, leaves, and bark have been used in traditional Chinese medicine for treating various conditions like diarrhea, insomnia, and skin diseases. Its active compounds include flavonoids, saponins, and alkaloids, which contribute to its medicinal properties.

It is essential to note that the use of Sophora species or their extracts in a medical context should be based on scientific research and under professional medical supervision due to potential side effects and interactions with other medications.

Drug compounding is the process of combining, mixing, or altering ingredients to create a customized medication to meet the specific needs of an individual patient. This can be done for a variety of reasons, such as when a patient has an allergy to a certain ingredient in a mass-produced medication, or when a patient requires a different dosage or formulation than what is available commercially.

Compounding requires specialized training and equipment, and compounding pharmacists must follow strict guidelines to ensure the safety and efficacy of the medications they produce. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), but the FDA does regulate the ingredients used in compounding and has oversight over the practices of compounding pharmacies.

It's important to note that while compounding can provide benefits for some patients, it also carries risks, such as the potential for contamination or incorrect dosing. Patients should only receive compounded medications from reputable pharmacies that follow proper compounding standards and procedures.

A nanocapsule is a type of nanoparticle that is characterized by its hollow, spherical structure. It is composed of a polymeric membrane that encapsulates an inner core or "cargo" which can be made up of various substances such as drugs, proteins, or imaging agents. The small size of nanocapsules (typically ranging from 10 to 1000 nanometers in diameter) allows them to penetrate cells and tissue more efficiently than larger particles, making them useful for targeted drug delivery and diagnostic applications.

The polymeric membrane can be designed to be biodegradable or non-biodegradable, depending on the desired application. Additionally, the surface of nanocapsules can be functionalized with various moieties such as antibodies, peptides, or small molecules to enhance their targeting capabilities and improve their stability in biological environments.

Overall, nanocapsules have great potential for use in a variety of medical applications, including cancer therapy, gene delivery, and vaccine development.

In medical terms, "gels" are semi-solid colloidal systems in which a solid phase is dispersed in a liquid medium. They have a viscous consistency and can be described as a cross between a solid and a liquid. The solid particles, called the gel network, absorb and swell with the liquid component, creating a system that has properties of both solids and liquids.

Gels are widely used in medical applications such as wound dressings, drug delivery systems, and tissue engineering due to their unique properties. They can provide a moist environment for wounds to heal, control the release of drugs over time, and mimic the mechanical properties of natural tissues.

Corneal edema is a medical condition characterized by the accumulation of fluid in the cornea, which is the clear, dome-shaped surface at the front of the eye. This buildup of fluid causes the cornea to swell and thicken, resulting in blurry or distorted vision. Corneal edema can be caused by various factors, including eye injuries, certain medications, eye surgeries, and diseases that affect the eye's ability to pump fluids out of the cornea. In some cases, corneal edema may resolve on its own or with treatment, but in severe cases, it may require a corneal transplant.

Medical technology, also known as health technology, refers to the use of medical devices, medicines, vaccines, procedures, and systems for the purpose of preventing, diagnosing, or treating disease and disability. This can include a wide range of products and services, from simple devices like tongue depressors and bandages, to complex technologies like MRI machines and artificial organs.

Pharmaceutical technology, on the other hand, specifically refers to the application of engineering and scientific principles to the development, production, and control of pharmaceutical drugs and medical devices. This can include the design and construction of manufacturing facilities, the development of new drug delivery systems, and the implementation of quality control measures to ensure the safety and efficacy of pharmaceutical products.

Both medical technology and pharmaceutical technology play crucial roles in modern healthcare, helping to improve patient outcomes, reduce healthcare costs, and enhance the overall quality of life for individuals around the world.

In the context of medical and health sciences, particle size generally refers to the diameter or dimension of particles, which can be in the form of solid particles, droplets, or aerosols. These particles may include airborne pollutants, pharmaceutical drugs, or medical devices such as nanoparticles used in drug delivery systems.

Particle size is an important factor to consider in various medical applications because it can affect the behavior and interactions of particles with biological systems. For example, smaller particle sizes can lead to greater absorption and distribution throughout the body, while larger particle sizes may be filtered out by the body's natural defense mechanisms. Therefore, understanding particle size and its implications is crucial for optimizing the safety and efficacy of medical treatments and interventions.

Polysorbates are a type of nonionic surfactant (a compound that lowers the surface tension between two substances, such as oil and water) commonly used in pharmaceuticals, foods, and cosmetics. They are derived from sorbitol and reacted with ethylene oxide to create a polyoxyethylene structure. The most common types of polysorbates used in medicine are polysorbate 20, polysorbate 40, and polysorbate 60, which differ in the number of oxyethylene groups in their molecular structure.

Polysorbates are often added to pharmaceutical formulations as emulsifiers, solubilizers, or stabilizers. They help to improve the solubility and stability of drugs that are otherwise insoluble in water, allowing for better absorption and bioavailability. Polysorbates can also prevent the aggregation and precipitation of proteins in injectable formulations.

In addition to their use in pharmaceuticals, polysorbates are also used as emulsifiers in food products such as ice cream, salad dressings, and baked goods. They help to mix oil and water-based ingredients together and prevent them from separating. In cosmetics, polysorbates are used as surfactants, solubilizers, and stabilizers in a variety of personal care products.

It is important to note that some people may have allergic reactions to polysorbates, particularly those with sensitivities to sorbitol or other ingredients used in their production. Therefore, it is essential to carefully consider the potential risks and benefits of using products containing polysorbates in individuals who may be at risk for adverse reactions.

Benzalkonium compounds are a group of related chemicals that have antimicrobial properties. They are commonly used as disinfectants and preservatives in various products such as eye drops, nasal sprays, skin creams, and household cleaners. Benzalkonium compounds work by disrupting the cell membranes of bacteria, fungi, and viruses, leading to their death. They are often used in low concentrations and are generally considered safe for topical use, but they can cause irritation and allergic reactions in some people. Prolonged or frequent use of products containing benzalkonium compounds may also lead to the development of bacterial resistance.

"Administration, Rectal" is a medical term that refers to the process of administering medication or other substances through the rectum. This route of administration is also known as "rectal suppository" or "suppository administration."

In this method, a solid dosage form called a suppository is inserted into the rectum using fingers or a special applicator. Once inside, the suppository melts or dissolves due to the body's temperature and releases the active drug or substance, which then gets absorbed into the bloodstream through the walls of the rectum.

Rectal administration is an alternative route of administration for people who have difficulty swallowing pills or liquids, or when rapid absorption of the medication is necessary. It can also be used to administer medications that are not well absorbed through other routes, such as the gastrointestinal tract. However, it may take longer for the medication to reach the bloodstream compared to intravenous (IV) administration.

Common examples of rectally administered medications include laxatives, antidiarrheal agents, analgesics, and some forms of hormonal therapy. It is important to follow the instructions provided by a healthcare professional when administering medication rectally, as improper administration can reduce the effectiveness of the medication or cause irritation or discomfort.

Polyethylene glycols (PEGs) are a family of synthetic, water-soluble polymers with a wide range of molecular weights. They are commonly used in the medical field as excipients in pharmaceutical formulations due to their ability to improve drug solubility, stability, and bioavailability. PEGs can also be used as laxatives to treat constipation or as bowel cleansing agents prior to colonoscopy examinations. Additionally, some PEG-conjugated drugs have been developed for use in targeted cancer therapies.

In a medical context, PEGs are often referred to by their average molecular weight, such as PEG 300, PEG 400, PEG 1500, and so on. Higher molecular weight PEGs tend to be more viscous and have longer-lasting effects in the body.

It's worth noting that while PEGs are generally considered safe for use in medical applications, some people may experience allergic reactions or hypersensitivity to these compounds. Prolonged exposure to high molecular weight PEGs has also been linked to potential adverse effects, such as decreased fertility and developmental toxicity in animal studies. However, more research is needed to fully understand the long-term safety of PEGs in humans.

A drug carrier, also known as a drug delivery system or vector, is a vehicle that transports a pharmaceutical compound to a specific site in the body. The main purpose of using drug carriers is to improve the efficacy and safety of drugs by enhancing their solubility, stability, bioavailability, and targeted delivery, while minimizing unwanted side effects.

Drug carriers can be made up of various materials, including natural or synthetic polymers, lipids, inorganic nanoparticles, or even cells and viruses. They can encapsulate, adsorb, or conjugate drugs through different mechanisms, such as physical entrapment, electrostatic interaction, or covalent bonding.

Some common types of drug carriers include:

1. Liposomes: spherical vesicles composed of one or more lipid bilayers that can encapsulate hydrophilic and hydrophobic drugs.
2. Polymeric nanoparticles: tiny particles made of biodegradable polymers that can protect drugs from degradation and enhance their accumulation in target tissues.
3. Dendrimers: highly branched macromolecules with a well-defined structure and size that can carry multiple drug molecules and facilitate their release.
4. Micelles: self-assembled structures formed by amphiphilic block copolymers that can solubilize hydrophobic drugs in water.
5. Inorganic nanoparticles: such as gold, silver, or iron oxide nanoparticles, that can be functionalized with drugs and targeting ligands for diagnostic and therapeutic applications.
6. Cell-based carriers: living cells, such as red blood cells, stem cells, or immune cells, that can be loaded with drugs and used to deliver them to specific sites in the body.
7. Viral vectors: modified viruses that can infect cells and introduce genetic material encoding therapeutic proteins or RNA interference molecules.

The choice of drug carrier depends on various factors, such as the physicochemical properties of the drug, the route of administration, the target site, and the desired pharmacokinetics and biodistribution. Therefore, selecting an appropriate drug carrier is crucial for achieving optimal therapeutic outcomes and minimizing side effects.

In the context of medical terminology, "powders" do not have a specific technical definition. However, in a general sense, powders refer to dry, finely ground or pulverized solid substances that can be dispersed in air or liquid mediums. In medicine, powders may include various forms of medications, such as crushed tablets or capsules, which are intended to be taken orally, mixed with liquids, or applied topically. Additionally, certain medical treatments and therapies may involve the use of medicated powders for various purposes, such as drying agents, abrasives, or delivery systems for active ingredients.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Micelles are structures formed in a solution when certain substances, such as surfactants, reach a critical concentration called the critical micelle concentration (CMC). At this concentration, these molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) components, arrange themselves in a spherical shape with the hydrophilic parts facing outward and the hydrophobic parts clustered inside. This formation allows the hydrophobic components to avoid contact with water while the hydrophilic components interact with it. Micelles are important in various biological and industrial processes, such as drug delivery, soil remediation, and the formation of emulsions.

Temperature, in a medical context, is a measure of the degree of hotness or coldness of a body or environment. It is usually measured using a thermometer and reported in degrees Celsius (°C), degrees Fahrenheit (°F), or kelvin (K). In the human body, normal core temperature ranges from about 36.5-37.5°C (97.7-99.5°F) when measured rectally, and can vary slightly depending on factors such as time of day, physical activity, and menstrual cycle. Elevated body temperature is a common sign of infection or inflammation, while abnormally low body temperature can indicate hypothermia or other medical conditions.

Ionic liquids are not a medical term, but rather a term used in the field of chemistry and physics. They refer to salts that exist in the liquid state at temperatures below 100 degrees Celsius. Ionic liquids are composed entirely of ions and have unique properties such as low volatility, high thermal stability, and good conductivity, making them useful in various applications including chemical reactions, energy storage, and biomedical devices. However, they do not have a direct relation to medical definitions or healthcare.

No FAQ available that match "poloxamer"

No images available that match "poloxamer"